Growth-Hormone Treatment Effective In Short But Healthy Children
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Growth-Hormone Treatment Effective In Short But Healthy Children

STANFORD, CT -- Feb. 18, 1999 -- Doctors have long used injections of human growth hormone to treat children who are short because of abnormally low levels of this growth-stimulating substance. But now, a decade-long study led by a Stanford researcher shows that the same treatment also stimulates growth in short but healthy children.

Stanford professor of pediatrics Raymond Hintz, MD, and his colleagues gave regular injections of growth hormone to 121 children who ranked in the bottom three percent of their age group in height. All of the children had normal levels of growth hormone in their blood but showed below-average growth rates. The treatment spanned between two and 10 years, depending on the age of the child.

To determine whether the growth hormone made a difference, the researchers estimated how tall each child would have grown based on the average height of his or her parents.

Of the 80 children who reached their adult size by the end of the study, boys surpassed their predicted height by an average of five centimetres -- roughly two inches. The girls grew nearly six centimetres over the predicted values.

A comparison of the treated children to a comparable group of children who received no growth hormone gave similar results. Treated boys outgrew the untreated boys by 9.2 centimetres (about three-and-a-half inches). For girls, the disparity was 5.7 centimetres.

At present, growth hormone is approved for use only when the child lacks sufficient natural growth hormone, has an aberration of the chromosomes called Turner's syndrome, or has failing kidneys and is awaiting a transplant.

"The difficult questions of the ethical and financial justification of growth hormone treatment for these children with severe short stature must be faced squarely," the authors write.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities